uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted January 17, 2018

Joint and Pain Relief Product Contains Undeclared Drug

On January 17, 2018 Health Canada warned consumers that Linsen Double Caulis Plus, a supplement for joint pain, was found to contain the undeclared drug dexamethasone.

Dexamethasone can cause changes in blood sugar and blood pressure, damage bones, and cause adrenal suppression when taken in high doses for a prolonged period.

Consumers who have taken Linsen Double Caulis Plus should immediately consult with their healthcare provider and stop taking it only under medical supervision, as abruptly discontinuing dexamethasone can cause life-threatening adrenal suppression and withdrawal syndrome.

See's Review of Joint Health Supplements for tests of related products.

See related recall and warnings:

FDA Warning on Supplement for Pain Relief

FDA Warns of Life-Threatening Side Effects and Withdrawal Symptoms from Two Arthritis, Muscle Pain Supplements

Arthritis and Muscle Pain Supplement Contains Prescription Drugs

To read Health Canada's full warning, use the link.